» Articles » PMID: 3499668

Interaction of a Liver-specific Nuclear Factor with the Fibrinogen and Alpha 1-antitrypsin Promoters

Overview
Journal Science
Specialty Science
Date 1987 Oct 30
PMID 3499668
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

The orderly and sequential activation of genes during development is hypothesized to be related to the selective expression of groups of regulatory proteins acting primarily at the level of transcription. A nuclear protein was found in hepatocytes, but not other cell types, that binds to a sequence required for hepatocyte-specific transcription of the gene for the beta chain of fibrinogen. This protein, hepatocyte nuclear factor 1 (HNF1), also interacts with homologous sequences required for optimal promoter function of the genes for the alpha chain of fibrinogen and alpha 1-antitrypsin. The promoter or enhancer regions for several viral and cellular genes not expressed in the liver did not compete for this binding. The restricted expression of HNF1 and its selective interaction with the control regions of several liver-specific genes indicate that it is involved in developmentally regulated gene expression in the liver.

Citing Articles

Regulation of fibrinogen synthesis.

Dobson D, Fish R, de Vries P, Morrison A, Neerman-Arbez M, Wolberg A Thromb Res. 2024; 242:109134.

PMID: 39216273 PMC: 11381137. DOI: 10.1016/j.thromres.2024.109134.


Epigenetic and transcriptional regulation of the human angiotensinogen gene by high salt.

Perla S, Kumar A bioRxiv. 2023; .

PMID: 38045346 PMC: 10690268. DOI: 10.1101/2023.11.22.568343.


HNF4α isoforms: the fraternal twin master regulators of liver function.

Radi S, Vemuri K, Martinez-Lomeli J, Sladek F Front Endocrinol (Lausanne). 2023; 14:1226173.

PMID: 37600688 PMC: 10438950. DOI: 10.3389/fendo.2023.1226173.


A pharmacoproteomic landscape of organotypic intervention responses in Gram-negative sepsis.

Mohanty T, Karlsson C, Chao Y, Malmstrom E, Bratanis E, Grentzmann A Nat Commun. 2023; 14(1):3603.

PMID: 37330510 PMC: 10276868. DOI: 10.1038/s41467-023-39269-9.


Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.

Lehtio J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O Nat Cancer. 2021; 2(11):1224-1242.

PMID: 34870237 PMC: 7612062. DOI: 10.1038/s43018-021-00259-9.